Revolutionary Insights into Human BBB Development
Chinese researchers from the Chinese Academy of Sciences (CAS) have unveiled a groundbreaking study that deciphers how neural cells orchestrate the formation of the blood-brain barrier (BBB) during early human brain development. Published in the prestigious journal Cell Stem Cell on March 23, 2026, the research provides the first spatiotemporal transcriptomic atlas of the BBB in human fetal cortex from gestational weeks (GW) 6 to 21. This work highlights the pivotal role of neural cells in inducing BBB-specific functions through Cadherin-2 (CDH2)-mediated signaling, marking a significant advancement in neuroscience.
The blood-brain barrier, a highly selective semipermeable border formed by endothelial cells (ECs) lining brain capillaries, astrocytes, pericytes, and basement membrane components, protects the central nervous system (CNS) from harmful blood-borne substances while allowing essential nutrients like glucose and oxygen to pass. Its dysfunction is implicated in numerous neurological disorders, making this discovery timely for China's growing burden of such conditions.
The Critical Role of the Blood-Brain Barrier in Brain Health
The BBB maintains CNS homeostasis by regulating molecular and ionic fluxes between blood and brain parenchyma. Composed primarily of brain microvascular endothelial cells with tight junctions (TJs) formed by proteins like claudin-5, occludin, and ZO-1, the barrier prevents entry of pathogens, toxins, and large molecules while facilitating transport via specific carriers and efflux pumps like P-glycoprotein. Pericytes and astrocyte end-feet further stabilize this structure, ensuring low paracellular permeability unique to CNS vasculature compared to peripheral vessels.
In China, where rapid aging is amplifying neurodegenerative disease prevalence, BBB integrity is paramount. Alzheimer's disease and related dementias (ADRD) affect nearly 13 million people as of recent estimates, representing about 30% of the global total, with projections indicating a surge to over 45 million cases by 2050. Stroke, the leading cause of death and disability, impacts millions annually, often involving BBB disruption that exacerbates brain injury. Understanding developmental mechanisms could unlock preventive and therapeutic strategies tailored to China's population.
Unraveling BBB Ontogeny Through Advanced Transcriptomics
Led by Zhongqiu Li and Yanxin Li from CAS's Institute of Zoology and the University of Chinese Academy of Sciences (UCAS), the team employed single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (scStereo-seq, MERFISH) on human fetal cortex samples. This approach mapped neurovascular unit (NVU) cell types—ECs, pericytes, smooth muscle cells, astrocytes, neurons, and neural progenitors—across developmental stages.
Key observation: BBB-specific transporter expression emerged uniformly in all EC subclusters by GW8, earlier than previously thought. This signature included nutrient transporters (e.g., GLUT1 for glucose) and efflux pumps, conserved between human and mouse models.
Neural Cells Drive BBB Induction via CDH2 Signaling
The study's core revelation: Neural cells, particularly neurons and progenitors, actively induce BBB properties in ECs through Cadherin-2 (CDH2, or N-cadherin), a cell adhesion molecule. CDH2 on neural cells interacts homophilically with EC CDH2, activating β-catenin signaling in ECs to upregulate BBB genes.
Step-by-step mechanism:
- 1. Adhesion formation: CDH2-CDH2 homotypic binding between neural cells and ECs.
- 2. Signal transduction: Activates canonical Wnt/β-catenin pathway in ECs.
- 3. Transcriptional response: Upregulates TJ proteins, transporters (e.g., SLC2A1/GLUT1), and suppresses fenestral diapedesis genes.
- 4. Barrier maturation: Reduced permeability, enhanced selectivity.
Experimental validation via co-culture confirmed CDH2 blockade disrupts induction, underscoring its necessity. View the full study for detailed data: Cell Stem Cell publication.
Neural Progenitors Boost Mural Cell Coverage
Parallelly, neural progenitor cells (NPCs) promote pericyte and smooth muscle cell proliferation via signaling ligands, intensifying EC-mural interactions post-GW8. This synchronizes with BBB onset, ensuring robust vascular stability essential for cortical expansion.
In China, where stroke prevalence is projected to rise 119% by 2050, fortifying BBB via such pathways could mitigate secondary injury cascades.
Photo by BoliviaInteligente on Unsplash
H2A.Z.1: A Novel Regulator of Angiogenesis and BBB
The team identified histone variant H2A.Z.1 as a critical modulator. Enriched in ECs, it governs angiogenesis and BBB gene expression. Depletion impairs vessel sprouting and barrier formation, linking epigenetics to vascular development.
This finding opens avenues for epigenetic therapies, aligning with CAS's leadership in stem cell and regenerative medicine research.
CAS and UCAS: Pillars of Chinese Neuroscience Excellence
The University of Chinese Academy of Sciences (UCAS), ranked #54 globally by U.S. News and top in China for research output, trains over 60,000 graduate students across CAS institutes. The Institute of Zoology, a UCAS hub, excels in developmental biology, with this study exemplifying interdisciplinary prowess in single-cell omics.
Such breakthroughs attract global talent, fostering PhD programs in neuroscience. UCAS neuroscience ranks among China's elite, producing leaders like Mu-ming Poo, bolstering national R&D in brain health.
Implications for Neurodegenerative Therapies
BBB dysfunction precedes pathology in AD, stroke, and multiple sclerosis. In China, neurological disorders caused 78 million disability-adjusted life years (DALYs) in 2021 alone. Targeting CDH2 or H2A.Z.1 could enhance drug delivery, vital as most CNS therapeutics fail BBB penetration.
For instance, activating neural-EC signaling might restore barrier integrity post-stroke, reducing edema and hemorrhage. Explore related advances in CAS pericyte research.
Comparative Insights: Human vs. Mouse Models
Remarkably, human-mouse conservation validates rodent models for preclinical testing, accelerating translation. However, human-specific timings (GW8 onset) emphasize organoid models for precision medicine.
- Benefits: Cost-effective, ethical screening of BBB-modulating compounds.
- Risks: Species differences in transporter profiles.
- Comparisons: Mouse BBB matures E12.5-P7, akin to human GW8-21.
Future Directions and Challenges
Upcoming research at CAS/UCAS may integrate CRISPR editing of CDH2 in organoids to test causality. Clinical trials targeting β-catenin agonists loom, potentially revolutionizing treatments for China's 468 million neurological cases.
Challenges include ethical sourcing of fetal tissue and scaling spatial omics. Yet, this positions Chinese higher education as a global neuroscience vanguard.
Photo by Wolfgang Hasselmann on Unsplash
Cultivating Neuroscience Talent in China
UCAS's graduate programs in stem cell biology and neurodevelopment equip students with tools like scRNA-seq, vital for such discoveries. With rising demand for neuro researchers amid aging demographics, opportunities abound in CAS labs and universities like Peking Union Medical College.
This study exemplifies how collaborative training yields world-class outputs, inspiring the next generation to tackle brain health challenges.